GM

Garima Mishra

Active Director Director DIN 10361111
DIN 10361111 First appointment Oct 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Garima Mishra

Data last updated:

Garima Mishra is a Director at Agns Hospital Private Limited (since 2023). The company operates in Healthcare. Agns Hospital Private Limited reported revenue of ₹5.88 Cr (FY 2025).

DIN 10361111
Primary Designation Director
Industry Healthcare
First Appointment 18 Oct 2023
Oldest Company Age 3 yrs
Largest company Agns Hospital Private Limited · ₹5.88 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agns Hospital Private Limited U86100UP2023PTC191053
Director18 Oct 20232023₹5.88 Cr (FY 2025)Active

Board colleagues of Garima Mishra

NameDINCompanyDesignation
Arvind Kumar Mishra10361110Agns Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Agns Hospital Private Limited
Premium access

Shareholding and investment profile for Garima Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Garima Mishra

Garima Mishra currently holds 1 directorship: Agns Hospital Private Limited (Director, since 18 Oct 2023, revenue ₹5.88 Cr (FY 2025)).

Garima Mishra was first appointed on 18 Oct 2023 as Director at Agns Hospital Private Limited.

The current boards of Garima Mishra's companies include Arvind Kumar Mishra (Agns Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available